Soluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathology
about
Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza InfectionCoadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with OseltamivirNon-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Tissue-protective effects of NKG2A in immune-mediated clearance of virus infection.Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance.Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways.Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitude.Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity.Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections.Effects of different anesthesia methods on postoperative transient neurological syndrome in patients with lumbar disc herniation.Curative effect of minimally invasive surgery on palmar and foot hyperhidrosis and its influence on serum-related cytokines and immunoglobulins.Advancements in Host-Based Interventions for Influenza TreatmentTreating Influenza Infection, From Now and Into the Future
P2860
Q26767517-9DAD23BD-1E3F-4D24-B7E5-C21FE7161D76Q28548533-3506EF26-0BDD-4007-8852-85C03EDA4449Q30395259-F6BEA824-5A62-4B1C-A147-9F620E128777Q30410322-9DE7E4EE-4451-4BE7-84BE-BF7253D3A05CQ35071454-B117DD20-E649-466E-A605-6EE697C17ACCQ35275348-5BCAE8D3-F3A2-4E49-B1C6-457BE922FF41Q37727159-E460F91D-7BCB-47E0-9D4A-B6530D336301Q40050773-12857C75-17EF-4480-8E5F-A4FE255F8942Q40092134-6D0F8CA5-B1C1-4DB5-AE3E-07F810C00FA1Q40717220-F7BC2771-0866-4855-8E93-A2065102681FQ41665126-6D0179A3-30A4-4E79-89D2-D7BAFDB85B67Q55220668-0DC152DB-2723-42B4-8633-3B8E599AEBA1Q56996774-C80F7BA0-7587-4A15-A145-6D8388BDD44FQ57158941-9E43DE04-5956-45CB-B939-007367840E8B
P2860
Soluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathology
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Soluble, but not transmembrane ...... the extent of immunopathology
@ast
Soluble, but not transmembrane ...... the extent of immunopathology
@en
type
label
Soluble, but not transmembrane ...... the extent of immunopathology
@ast
Soluble, but not transmembrane ...... the extent of immunopathology
@en
prefLabel
Soluble, but not transmembrane ...... the extent of immunopathology
@ast
Soluble, but not transmembrane ...... the extent of immunopathology
@en
P2093
P2860
P356
P1476
Soluble, but not transmembrane ...... the extent of immunopathology
@en
P2093
Kenneth H Ely
Matthew P DeBerge
Richard I Enelow
P2860
P304
P356
10.4049/JIMMUNOL.1302729
P407
P577
2014-04-30T00:00:00Z